Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack

Drug and Alcohol Dependence

Volumn 58, Issue 3, 2000, Pages 219-226

  Booth, Robert E ^a   Kwiatkowski, Carol F ^a   Chitwood, Dale D ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Crack; HIV; Injection drug user; Sex risk

Indexed keywords

COCAINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; CONDOM; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SEXUAL BEHAVIOR; SMOKING;

ADULT; COCAINE-RELATED DISORDERS; CRACK COCAINE; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0034159920     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00094-0     Document Type: Article

References (50)

1. Alcabes P., Friedland G. Injection drug use and human immunodeficiency virus infection. Clin. Infect. Dis. 20:1995;1467-1479.
2. Astemborski J., Vlahov D., Warren D., Solomon L., Nelson K.E. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am. J. Public Health. 84:1994;382-387.
3. Barre-Sinoussi F., Chermann J.C., Ref F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for the acquired immunodeficiency syndrome (AIDS). Science. 220:1983;868-871.
4. Battjes R.J., Pickens R.W., Amsel Z., Brown L.S. Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J. Infect. Dis. 162:1990;1007-1011.
5. Booth R.E., Crowley T.C., Zhang Y. Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Dep. 42:1996;11-20.
6. Booth R.E., Koester S., Brewster J.T., Wiebel W.W., Fritz R.B. Intravenous drug users and AIDS: risk behaviors. Am. J. Drug Alcohol Abuse. 17:1991;337-353.
7. Booth R.E., Watters J.K., Chitwood D.D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am. J. Public Health. 83:1993;1144-1147.
8. Bulterys M., Chao A., Dushimimana A. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS. 7:1993;1639-1645.
9. Centers for Disease Control and Prevention, 1997. HIV/AIDS Surveillance Report 9, 8-12.
10. Centers for Disease Control and Prevention, 1988. Syphilis and congenital syphilis - United States, 1985-1988. MMWR 37, 486-488.
11. Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., Moss A.R. Cocaine use and HIV infection in intravenous drug users in San Francisco. J. Am. Med. Assoc. 261:1989;581-585.
12. Chaisson M.A., Stoneburner R.L., Hilderbrandt D.S., Ewing W.E., Telzak E.E., Jafee H.A. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS. 5:1991;1121-1126.
13. Chirgwin K., DeHovitz J.A., Dillon S., McCormack W.M. HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. Am. J. Public Health. 81:1991;1576-1579.
14. Choopanya K., Vanichseni S., Plangsringarm K. et al. Risk factors and HIV seropositivity among injection drug users in Bangkok. AIDS. 5:1991;1509-1513.
15. Coutinho R.A. Epidemiology and prevention of AIDS among intravenous drug users. AIDS. 3:1990;413-416.
16. Deren S., Kotranski L., Beardsley M. et al. Crack users in East Harlem, New York and Philadelphia, Pennsylvania: HIV-related risk behaviors and predictors of serostatus. Am. J. Drug Alcohol Abuse. 23:1997;555-567.
17. Des Jarlais D.C., Friedman S.R. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1:1987;67-76.
18. Dowling-Guyer S., Johnson M.E., Fisher D.G. Reliability of drug users self-reported recent drug use. Assessment. 1:1994;383-392.
19. Edlin B.R., Irwin K.L., Faruque S. et al. Intersecting epidemics - crack cocaine use and HIV infection among inner-city young adults. New Engl. J. Med. 331:1994;1422-1427.
20. Friedland G.H., Klein R.S. Transmission of the human immunodeficiency virus. New Engl. J. Med. 317:1987;1125-1135.
21. Fullilove R.E., Fullilove M.T., Bowser B., Gross S. Crack users: the new AIDS risk group? Cancer Detection and Prevention. 14:1990;363-368.
22. Fullilove M.T., Lown E.A., Fullilove R.E. Crack 'hos and skeezers: traumatic experiences of women crack users. J. Sex Res. 29:1992;275-287.
23. Hearst N., Hulley S.B. Preventing the heterosexual spread of AIDS: are we giving our patients the best advice? J. Am. Med. Assoc. 259:1988;2428-2432.
24. Inciardi J.A., Chitwood D.D., McCoy C.B. Special risks for the acquisition and transmission of HIV infection during sex in crack houses. [Letter]. J. Acquir. Immun. Def. Syndr. 5:1992;951-952.
25. Irwin K.L., Edlin B.R., Faruque S. et al. Crack smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV infection. Drug Alcohol Dep. 42:1996;85-92.
26. Irwin, K., Edlin, B., Ludwig, D., Wood, C., Serrano, Y., Inciardi, J., 1991. HIV infection in street-recruited crack smokers in 3 cities. Presented at the 119th Annual Meeting of the Am. Public Health Association. Atlanta, GA.
27. James N.J., Bignell C.J., Gillies P.A. The reliability of self-reported sexual behavior. AIDS. 5:1991;333-336.
28. Khalsa M.E., Kowalewski M.R., Lunn R., Anglin M.D., Miller K.A. AIDS-related knowledge, beliefs and risk behaviors in a sample of crack addicts. J. Drug Issues. 24:1994;537-553.
29. Kim M.Y., Marmour M., Dublin N., Wolfe H. HIV risk-related sexual behaviors among heterosexuals in New York City: associations with race, sex, and intravenous drug use. AIDS. 7:1993;409-414.
30. Koblin B.A., McCusker J., Lewis B.F., Sullivan J.L. Race/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study. Am. J. Epid 132:1990;837-846.
31. Koester S., Booth R.E., Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J. Acquir. Immun. Defic. Syndr. Human Retrovirol. 12:1996;1202-1207.
32. Longshore D., Anglin M.D. Number of sex partners and crack cocaine use: is crack an independent marker for HIV risk behavior? J. Drug Issues. 25:1995;1-10.
33. Magura S., Goldsmith D.S., Casriel C., Goldstein P.J., Lipton D.C. The validity of methadone clients' self-reported drug use. Internat. J. Add. 22:1987;727-749.
34. Marmor M., Des Jarlais D.C., Cohen H. et al. Risk factors for infection with human immunodeficiency virus among intravenous drug. AIDS. 1:1987;39-44.
35. McElrath K., Chitwood D.D., Griffin D.K., Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am. J. Public Health. 84:1994;1965-1970.
36. Murphy D.L. Heterosexual contacts of intravenous drug users. Implications for the next spread of the AIDS epidemic. Advances Alcohol Subs. Abuse. 3:1988;89-97.
37. Nelson K.E., Celentano D.D., Suprasert S. et al. Risk factors for HIV infection among young adult men in Northern Thailand. J. Am. Med. Assoc. 270:1993;955-960.
38. New York City Department of Health, 1989. Congenital syphilis, its prevention and control. City Health Information. 8(6).
39. Nicolosi A., Correa Leite M.L., Musicco M. et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am. J. Epid 135:1992;225-233.
40. Robertson J.R., Skidmore C.A., Roberts J.K. HIV infection in intravenous drug users a follow-up study indicating changes in risk-raking behavior. Br. J. Add. 83:1988;387-391.
41. Saxon A.J., Calsyn D.A., Whittaker S., Freeman G. Sexual behaviors of intravenous drug users in treatment. J. of Acquir. Immun. Defic. Syndr. 4:1991;938-944.
42. Schoenbaum E.E., Hartel D., Selwyn P.A. et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl. J. Med. 321:1989;874-879.
43. Schultz S., Zwerig M., Singh T., Htoo M. Congenital syphilis - New York City, 1986-1988. MMWR. 38:1989;825-829.
44. Siraprapasiri T., Thanprasertsuk S., Rodklay A., Srivanichakorn S., Sawanpanyalert P., Temtanarak J. Risk factors for HIV among prostitute in Chiangmai, Thailand. AIDS. 5:1991;579-582.
45. Sterk C. Cocaine and HIV seropositivity. [Letter] The Lancet. 1:1988;1052-1053.
46. Vlahov D., Munoz A., Anthony J.C., Cohn S., Celentano D.D., Nelson K.E. Association of drug injection patterns with antibody to immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epid 132:1990;847-856.
47. Watkins K.E., Metzger D., Woody G., McLellan A.T. Determinants of condom use among intravenous drug users. AIDS. 7:1993;719-723.
48. Weatherby N.L., Needle R., Cesari C. et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. J. Ed. Prog. Plan. 17:1994;347-355.
49. Weatherby N.L., Schultz J.M., Chitwood D.D. et al. Crack cocaine use and sexual activity in Miami, Florida. J. Psychoactive Drugs. 24:1992;373-380.
50. Wiebel, W., Chene, D., Lampinen, T., et al., 1988. Intravenous drug users on the street: HIV seroprevalence and behavioral factors in an understudied high risk group. Presented at the 116th Annual meeting of the Am. Public Health Assoc. Boston, MA.